Exposure to per- and polyfluoroalkyl substances (PFAS), often called “forever chemicals,” may play a role in the development of inflammatory bowel disease (IBD) years before symptoms appear, according to a new five-year study supported by a $3.3 million National Institutes of Health (NIH) R01 grant to researchers at the Icahn School of Medicine at Mount Sinai.
Category: biotech/medical – Page 42
Mount Sinai Researchers Identify How APOE4 Gene Damages Brain Blood Vessels in Alzheimer’s Disease
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Millisecond-timescale, genetically targeted optical control of neural activity
Karl Deisseroth just won the Nobel Prize.
He showed that brain cells can be turned on/off by shining blue light on them, after inserting a light-sensitive protein from algae.
The method was named optogenetics and has been used worldwide to link specific neural circuits to behavior.
But Ed Boyden is the main author of this paper? I was wondering.
It’s a question many people in neuroscience are asking today, and there are a few layers to it.
First, what the prize actually honors. The 2026 Nobel in Physiology or Medicine went to Karl Deisseroth, Peter Hegemann, and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics” — essentially two scientific contributions: discovering the light-gated ion channel (Hegemann and Nagel’s channelrhodopsin work in the early 2000s) and turning it into a tool for controlling neurons (Deisseroth). Boyden’s name does appear in the Nobel committee’s own advanced documentation, which explicitly describes the 2005 paper as work by “Deisseroth, Nagel and collaborators” — the committee treats Deisseroth as the driving scientific force behind the neural-control half of the discovery.
Second, why first authorship doesn’t settle it. In the 2005 paper (Boyden, Zhang, Bamberg, Nagel, Deisseroth), Boyden was the first author, but Deisseroth was the senior/last author — meaning it was his lab, his conception of the project, and his scientific program. Nobel committees don’t reward authorship order; they try to identify who originated the decisive insight. Boyden was a graduate student at the time, doing the experiments within Deisseroth’s research program (Boyden himself has described working first in Richard Tsien’s lab, then moving into Deisseroth’s new Stanford lab in spring 2005).
AI Generated Youth Drugs Exist Now
The biggest thing in this is Sinclair mentioning A.I. turned 160 years worth of drug cocktail discovery into 2 months.
An AI designed a drug for a deadly lung disease, and six different aging clocks say it made people biologically younger. Rentosertib, from Insilico Medicine, was built to treat idiopathic pulmonary fibrosis. But when researchers ran patients’ blood through six proteomic aging clocks from six separate labs, all six read the treated patients as younger, by roughly 3 to 4 years at the peak.
We break down how AI found both the target and the molecule, what the new Nature Biotechnology paper actually shows (and what the hype got wrong), and why Insilico’s \.
How Radiation Therapy Kills Cancer Cells: When Does It Start Working?
How Radiation Therapy Kills Cancer Cells: When Does It Start Working? / apoptosis, cancer biology, Cancer Cells, cancer treatment, DNA damage, DNA
A Case of Coffee Enema Induced Rectal Burn, Proctocolitis, Sub-Acute Intestinal Obstruction, and Electrolyte Imbalance A Case Report
Coffee enemas are a form of complementary and alternative medicine (CAM) promoted by some practitioners and celebrities without credible scientific evidence. Their use is associated with several adverse effects, some of which can be life-threatening, including rectal burns, proctocolitis, intestinal obstruction, and electrolyte imbalances, which are well-documented but under reported. Only a handful of comparable cases exist in the literature, highlighting the need for greater clinician awareness and patient education. We present the case of a 30-year-old obese male with a recent diagnosis of T2 diabetes mellitus who developed severe proctocolitis, a fibrotic stricture leading to subacute intestinal obstruction, and a significant electrolyte imbalance following a self-administered hot coffee enema. The patient required intensive care management and partial colectomy was planned. This case report shows that coffee enema sometimes can cause serious complications. Healthcare providers and patients should be aware of the risk and should use coffee enema with caution.
Coffee Enema, Rectal Burn, Proctocolitis, Fibrotic Stricture, Subacute Intestinal Obstruction, Electrolyte Imbalance, Diabetes Mellitus, Alternative Medicine, Clinician Awareness, Patient Education
Brain circuit remembers stresses to help shape reactions to them
Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously overlooked brain circuit that helps explain how prior adversity can make the brain more reactive to future stress.
The study, published Sept. 30 in Nature and conducted in mice, identifies a small, deep brain structure called the anterior hypothalamic nucleus (AHN) as a critical hub that scales the brain’s response to threatening events. The research team found that dialing its activity up or down directly altered how strongly the animals responded to stress.
“Why do some people develop debilitating mental health conditions in response to stress while others do not? One known risk factor for heightened stress sensitivity is a history of prior stress, such as early childhood adversity or adult traumatic stress. However, at a biological level, we still do not fully understand why this is the case,” says Zachary Pennington, Ph.D., lead author of the paper, who conducted the research as a postdoctoral fellow in the Cai Lab at Mount Sinai and is now an assistant professor of psychology and a member of the Djavad Mowafaghian Centre for Brain Health at the University of British Columbia.
Life Biosciences to Present First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies at Eyecelerator 2026
BOSTON, October 1, 2026 – Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation medicines to reverse diseases of aging, today announced that the company will present new interim data from its Phase 1 clinical trial of ER-100 in patients with glaucoma in an oral session at Eyecelerator @ American Academy of Ophthalmology (AAO) 2026 being held in New Orleans, LA on October 8, 2026.
“People living with age-related vision loss like the two optic neuropathies we are currently focused on, open-angle glaucoma (OAG) and non-arteritic anterior ischemic optic neuropathy (NAION), have no therapeutic options that address the underlying damage to retinal ganglion cells. With ER-100, we are testing whether we can restore these cells to a more youthful state, not just slowing vision loss but potentially reversing it,” said Sharon Rosenzweig-Lipson, PhD, Chief Scientific Officer of Life Bio. “Being selected to present initial data from our Phase 1 study at Eyecelerator @ AAO is a meaningful validation of the impact of our work and we look forward to sharing our learnings with the broader scientific community.”
The Phase 1 first-in-human trial is evaluating the safety and tolerability of ER-100 in patients with optic neuropathies, with additional endpoints assessing visual function. ER‑100 is the first clinical candidate from Life Bio’s Epigenetic Restoration platform, which uses controlled expression of three transcription factors, OCT4, SOX2 and KLF4 (OSK) to restore cellular function by resetting the epigenetic code to induce more youthful patterns of gene expression.
The Best Human Longevity Lab (That You’ve Probably Never Heard Of)
Join us on Patreon! / michaellustgartenphd.
Discount Links/Affiliates:
Blood testing (where I get the majority of my labs, for those who blood test with Quest): https://www.ultalabtests.com/partners… those who blood test with LabCorp: https://www.anrdoezrs.net/click-10161… At-Home Metabolomics: https://www.iollo.com?ref=michael-lus… Use Code: CONQUERAGING At Checkout Clearly Filtered Water Filter: https://get.aspr.app/SHoPY Epigenetic, Telomere Testing: https://trudiagnostic.com/?irclickid=… Use Code: CONQUERAGING NAD+ Quantification: https://www.jinfiniti.com/intracellul… Use Code: ConquerAging At Checkout Oral Microbiome: https://www.bristlehealth.com/?ref=mi… Enter Code: ConquerAging SiphoxHealth Blood Testing (ApoB, GrimAge): https://siphoxhealth.com/mlustgarten Green Tea: https://www.ochaandco.com/?ref=fqbtflod Use Code: ML10OFF Diet Tracking: https://shareasale.com/r.cfm?b=139013… If you’d like to support the channel, you can do that with the website, Buy Me A Coffee: https://www.buymeacoffee.com/mlhnrca Conquer Aging Or Die Trying Merch! https://my-store-d4e7df.creator-sprin…
Blood Testing Essentials (Biological Age, CVD-Risk, Kidney Health and Function):
PhenoAge (Biological Age): https://www.ultalabtests.com/partners…
Measure the Bortz biomarkers: https://www.ultalabtests.com/partners…
Calculate your biological age using the Bortz clock: https://www.longevity-tools.com/human…
Reprogramming Life: Aging, Gender & Identity
Biology is Not Destiny.
For most of human history, aging seemed irreversible and the body’s fundamental characteristics appeared fixed. Today, advances in gene therapy, stem cell biology, epigenetics, and cellular reprogramming are challenging those assumptions and opening possibilities once considered impossible.
In Reprogramming Life, stem cell biologist and biotechnology entrepreneur Dana Larocca brings the history of biotechnology to life through the story of her own scientific career. Her journey begins with a childhood question—why do we grow old?—and leads to the frontiers of regenerative medicine and longevity research.
Along the way, Dana led the team that reprogrammed cells from a 114-year-old woman, showing that even cells from someone approaching the known limit of human lifespan could be returned to a youthful, embryonic-like state capable of becoming many different kinds of cells.
At the same time, she was living another story of transformation. From childhood, Dana knew herself to be female, but she kept that truth private for decades while building a career, marrying, and raising a family. She eventually transitioned at the age of sixty-three, giving the idea of biological flexibility a deeply personal meaning.
At its heart, Reprogramming Life asks how much of our biology is truly fixed—and what new choices may become possible as we learn to reprogram life itself.
🧬 Reprogramming the Biology of Life: Aging, Gender, & Identity.




